Britt B.M. Suelmann

602 total citations
31 papers, 214 citations indexed

About

Britt B.M. Suelmann is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Britt B.M. Suelmann has authored 31 papers receiving a total of 214 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 13 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Britt B.M. Suelmann's work include Cancer Risks and Factors (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Bladder and Urothelial Cancer Treatments (6 papers). Britt B.M. Suelmann is often cited by papers focused on Cancer Risks and Factors (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Bladder and Urothelial Cancer Treatments (6 papers). Britt B.M. Suelmann collaborates with scholars based in Netherlands, Australia and United Kingdom. Britt B.M. Suelmann's co-authors include P. J. van Diest, Elsken van der Wall, Carmen van Dooijeweert, Sabine C. Linn, Richard P. Meijer, Timon W. van Haeften, Ad den Boer, Elke Marsch, Robert de Vries and Gürbey Ocak and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Britt B.M. Suelmann

29 papers receiving 213 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Britt B.M. Suelmann Netherlands	7	95	44	30	29	27	31	214
Giulia Dondi Italy	11	45 0.5×	46 1.0×	25 0.8×	46 1.6×	11 0.4×	31	402
Jacob P. Hoogendam Netherlands	11	48 0.5×	38 0.9×	54 1.8×	37 1.3×	21 0.8×	32	279
Alan Heimann United States	10	56 0.6×	38 0.9×	51 1.7×	38 1.3×	14 0.5×	27	234
Huanmin Wang China	11	71 0.7×	44 1.0×	27 0.9×	48 1.7×	28 1.0×	31	260
Changbo Sun China	11	99 1.0×	66 1.5×	9 0.3×	27 0.9×	11 0.4×	26	270
Andrew Evans United Kingdom	7	34 0.4×	39 0.9×	31 1.0×	21 0.7×	15 0.6×	8	295
Maurizio Pinamonti Italy	9	30 0.3×	49 1.1×	33 1.1×	16 0.6×	8 0.3×	30	187
Nachi Palaniappan United Kingdom	8	73 0.8×	87 2.0×	23 0.8×	20 0.7×	12 0.4×	16	314
Ricardo Ribeiro Gama Brazil	8	91 1.0×	57 1.3×	31 1.0×	62 2.1×	25 0.9×	26	297
Glen Lo Australia	9	46 0.5×	43 1.0×	23 0.8×	44 1.5×	20 0.7×	26	233

Countries citing papers authored by Britt B.M. Suelmann

Since Specialization

Citations

This map shows the geographic impact of Britt B.M. Suelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Britt B.M. Suelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Britt B.M. Suelmann more than expected).

Fields of papers citing papers by Britt B.M. Suelmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Britt B.M. Suelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Britt B.M. Suelmann. The network helps show where Britt B.M. Suelmann may publish in the future.

Co-authorship network of co-authors of Britt B.M. Suelmann

This figure shows the co-authorship network connecting the top 25 collaborators of Britt B.M. Suelmann. A scholar is included among the top collaborators of Britt B.M. Suelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Britt B.M. Suelmann. Britt B.M. Suelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dijk, Nick van, Daniël J. Vis, Bram van den Broek, et al.. (2025). Final clinical analysis of pre-operative ipilimumab and nivolumab in locally advanced urothelial cancer and exploration of tumor-draining lymph node composition: The NABUCCO trial. European Journal of Cancer. 229. 115731–115731.

Preković, Stefan, Britt B.M. Suelmann, Janneke Verloop, et al.. (2025). Worse prognosis for breast cancer diagnosed in advanced pregnancy and shortly postpartum: an update of the Dutch pregnancy-associated breast cancer cohort. Breast Cancer Research and Treatment. 214(2). 191–204. 1 indexed citations

Dooijeweert, Carmen van, Tri Q. Nguyen, Michael Lynch, et al.. (2025). Prospective Clinical Implementation of Paige Prostate Detect Artificial Intelligence Assistance in the Detection of Prostate Cancer in Prostate Biopsies: CONFIDENT P Trial Implementation of Artificial Intelligence Assistance in Prostate Cancer Detection. JCO Clinical Cancer Informatics. 9(9). e2400193–e2400193. 2 indexed citations

Zondervan, Patricia, Rob Kessels, Johannes Berkhof, et al.. (2024). PrimerX: A Bayesian Multistage Cohort Embedded Randomised Trial to Evaluate the Role of Deferred Local Therapy of the Primary Tumour in Combination with Immune Checkpoint Inhibitor–based First-line Therapy in Metastatic Renal Cell Carcinoma Patients. European Urology Open Science. 70. 28–35. 1 indexed citations

Agarwal, Neeraj, James Brugarolas, Pooja Ghatalia, et al.. (2024). Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma. Annals of Oncology. 35(12). 1148–1156. 6 indexed citations

Atkins, Michael B., Pooja Ghatalia, Jaime R. Merchan, et al.. (2024). Belzutifan in patients with advanced clear cell renal cellcarcinoma (ccRCC): Subgroup analysis of the phase 2 LITESPARK-013 study.. Journal of Clinical Oncology. 42(16_suppl). 4534–4534. 1 indexed citations

Harlianto, Netanja I., et al.. (2024). Diagnostic accuracy of imaging modalities for detection of spinal metastases: a systematic review and meta-analysis. Clinical & Translational Oncology. 27(5). 2316–2326. 1 indexed citations

Luyendijk, Marianne, et al.. (2023). Comparison between de novo and metachronous metastatic breast cancer: the presence of a primary tumour is not the only difference—a Dutch population-based study from 2008 to 2018. Breast Cancer Research and Treatment. 198(2). 253–264. 5 indexed citations

Velden, Joanne M. van der, N. Kasperts, Janneke P.C. Grutters, et al.. (2023). Stereotactic Body radiotherapy and pedicLE screw fixatioN During one hospital visit for patients with symptomatic unstable spinal metastases: a randomized trial (BLEND RCT) using the Trials within Cohorts (TwiCs) design. Trials. 24(1). 307–307. 3 indexed citations

10.

Boellaard, Thierry N., Joost L. Boormans, Richard P. Meijer, et al.. (2023). Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial. Frontiers in Oncology. 13. 1246603–1246603. 3 indexed citations

11.

Richters, Anke, Debbie Robbrecht, Richard P. Meijer, et al.. (2023). Treatment Patterns and Use of Immune Checkpoint Inhibitors Among Patients with Metastatic Bladder Cancer in a Dutch Nationwide Cohort. European Urology Open Science. 59. 50–54. 1 indexed citations

12.

Egevad, Lars, Martin Eklund, Theodorus van der Kwast, et al.. (2022). Use of the ISUP e-learning module improves interrater reliability in prostate cancer grading. Journal of Clinical Pathology. 77(1). 22–26. 3 indexed citations

13.

Mous, Rogier, Roos J. Leguit, Lisette van de Corput, et al.. (2022). Hematologic malignancies following immune checkpoint inhibition for solid tumors. Cancer Immunology Immunotherapy. 72(1). 249–255. 5 indexed citations

14.

Suelmann, Britt B.M., Carmen van Dooijeweert, Janneke Verloop, et al.. (2022). Prognosis of pregnancy-associated breast cancer: inferior outcome in patients diagnosed during second and third gestational trimesters and lactation. Breast Cancer Research and Treatment. 192(1). 175–189. 7 indexed citations

15.

Suelmann, Britt B.M., et al.. (2022). Improving prediction of response to neoadjuvant treatment in patients with breast cancer by combining liquid biopsies with multiparametric MRI: protocol of the LIMA study – a multicentre prospective observational cohort study. BMJ Open. 12(9). e061334–e061334. 5 indexed citations

16.

Dooijeweert, Carmen van, Katja K.H. Aben, Britt B.M. Suelmann, et al.. (2022). Interlaboratory Gleason grading variation affects treatment: a Dutch historic cohort study in 30 509 patients with prostate cancer. Journal of Clinical Pathology. 76(10). 690–697. 3 indexed citations

17.

Suelmann, Britt B.M., Carmen van Dooijeweert, Elsken van der Wall, Sabine C. Linn, & P. J. van Diest. (2021). Pregnancy-associated breast cancer: nationwide Dutch study confirms a discriminatory aggressive histopathologic profile. Breast Cancer Research and Treatment. 186(3). 699–704. 25 indexed citations

18.

Suelmann, Britt B.M., et al.. (2021). Receptor status of breast cancer diagnosed during pregnancy: A literature review. Critical Reviews in Oncology/Hematology. 168. 103494–103494. 5 indexed citations

19.

Suelmann, Britt B.M., Manon N.G.J.A. Braat, P. J. van Diest, et al.. (2020). Phase I feasibility study of Magnetic Resonance guided High Intensity Focused Ultrasound-induced hyperthermia, Lyso-Thermosensitive Liposomal Doxorubicin and cyclophosphamide in de novo stage IV breast cancer patients: study protocol of the i-GO study. BMJ Open. 10(11). e040162–e040162. 24 indexed citations

20.

Boer, Ad den, et al.. (2011). Clustering of additional autoimmunity behaves differently in Hashimoto's patients compared with Graves' patients. European Journal of Endocrinology. 164(5). 789–794. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact